Navigation Links
Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards
Date:11/23/2009

dicated for the treatment of thrombocytopenia in patients with chronic immune thrombocytopenic purpura (ITP), under specific conditions that are further described below.

Chronic ITP is a serious autoimmune disorder characterized by low platelet counts in the blood (thrombocytopenia), which can lead to serious bleeding events. Nplate is the first platelet producer approved in both the U.S. and European Union (EU), and works by raising and sustaining platelet counts, representing a unique approach for the long-term treatment of this chronic disease.

The annual Scrip Awards are independently judged by a panel of senior industry experts and are given to biotechnology and pharmaceutical companies for their contribution to the improvement of health care. Amgen was one of the biggest winners among the dozen companies honored at the 2009 awards event for "outstanding achievements in the field of drug development," according to Scrip's press release. For more information, visit the Scrip website.

About Nplate

Nplate was the first platelet producer approved in the EU, Canada, Australia, Russia and the U.S. for chronic ITP. Nplate also has received orphan designation for chronic ITP in the U.S. (2003), the EU (2005), Switzerland (2005) and Japan (2006).

Nplate is the first treatment specifically developed for chronic ITP. It is also being investigated for potential use in pediatric ITP, myelodysplastic syndromes (MDS) and chemotherapy-induced thrombocytopenia (CIT).

In the U.S., Nplate is indicated for the treatment of thrombocytopenia in patients with chronic ITP who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy. Nplate should be used only in patients with ITP whose degree of thrombocytopenia and clinical condition increases the risk for bleeding. Nplate should not be used in an attempt to normalize platel
'/>"/>

Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
2. Medarex to Receive Milestone Payment from Amgen
3. AMT Obtains License to Amgens GDNF Gene to Develop Treatment for Parkinsons Disease with AMTs Proprietary Gene Therapy Platform
4. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
5. CDC Foundation Partners with Amgen, CDC to Reduce Infections Among Cancer Patients
6. Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
7. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
8. Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes
9. Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting
10. Call for Applications: The Amgen Award for Science Teaching Excellence
11. Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... Russia,s ... The Pharma 2020 Strategy provides incentives for local producers ... and foreign markets. These trends, however, were affected by ... following political and economic sanctions imposed on ... Russia responded to the ...
(Date:9/16/2014)... 2014 Research and Markets ... Laparoscopy Devices Industry Report 2014" report to ... Devices Industry Report 2014 is a professional and ... global laparoscopic devices. The report provides ... classifications, applications and industry chain structure. The laparoscopic ...
(Date:9/16/2014)... Sept. 16, 2014 Based on its ... Frost & Sullivan recognises Incisive Surgical with the ... Value Leadership. Incisive Surgical,s uniquely-designed, innovative INSORB® Absorbable ... eliminates the need for patients to undergo the ... removal  that may result in increased pain, wound ...
Breaking Medicine Technology:Global Medicines for Russia 2Global Laparoscopy Devices Industry Report 2014 2Frost & Sullivan Commends Incisive Surgical for Delivering Superior Customer Value through its Patient-Centric, Cost-Effective INSORB Absorbable Stapler 2Frost & Sullivan Commends Incisive Surgical for Delivering Superior Customer Value through its Patient-Centric, Cost-Effective INSORB Absorbable Stapler 3Frost & Sullivan Commends Incisive Surgical for Delivering Superior Customer Value through its Patient-Centric, Cost-Effective INSORB Absorbable Stapler 4Frost & Sullivan Commends Incisive Surgical for Delivering Superior Customer Value through its Patient-Centric, Cost-Effective INSORB Absorbable Stapler 5
(Date:9/16/2014)... (PRWEB) September 16, 2014 Transparency Market ... that the global facial care market is expected to ... The report, titled ‘Facial Care Market (By Product Type ... Wash, Cleansing Wipes, Serums and Masks and Others (fade ... Share, Growth, Trends and Forecast 2013 – 2019,’ is ...
(Date:9/16/2014)... 2014 Whatisfinalexpenseinsurance.com has released a ... affordable life insurance for seniors. , Finding affordable life ... A big part of the insurance market has moved ... tips that clients can use when shopping for life ... is important for providing financial security for vulnerable family ...
(Date:9/16/2014)... is effective in diagnosing concussion-related brain disease while a ... conducted at the Icahn School of Medicine at Mount ... Haven, and published September 16 in the journal ... that an experimental radiolabeled compound called [18 F]-T807, which ... that accumulates in the brain with repetitive blows to ...
(Date:9/16/2014)... Researchers at the Hebrew University of Jerusalem have ... at coaxing adult cells to become quality pluripotent ... and expanding area that aims to replace lost ... transplantation. Because stem cells derived from human embryos ... reprogramming adult cells back to an embryo-like state ...
(Date:9/16/2014)... Gary F. Locke, the former U.S. Ambassador to ... Group for exclusive representation of his global speaking activities. ... of Washington, Locke is widely recognized as one of ... and business growth. , “Gary Locke provides audiences with ... an organization’s global presence in and with China,” stated ...
Breaking Medicine News(10 mins):Health News:Global Facial Care Market Will Report a CAGR of 6.9% between 2013 and 2019: Transparency Market Research 2Health News:Global Facial Care Market Will Report a CAGR of 6.9% between 2013 and 2019: Transparency Market Research 3Health News:Life Insurance for Seniors - Clients Can Find Fast Life Insurance By Comparing Online Quotes! 2Health News:Neuroimaging technique identifies concussion-related brain disease in living brain 2Health News:Neuroimaging technique identifies concussion-related brain disease in living brain 3Health News:Scientists create therapy-grade stem cells using new cocktail to reprogram adult cells 2Health News:Gary Locke, Former Ambassador to China, Selects Worldwide Speakers Group for Exclusive Lecture Representation 2
... cells in the human brain is linked to learning and ... Florida. The research is the first to show such a ... upcoming print issue of the journal Brain , provide ... and reveal potential cellular targets for drug therapy. The ...
... HealthDay Reporter , WEDNESDAY, Aug. 25 (HealthDay News) -- ... 2008, nearly one in four American parents with health insurance ... to access the medical care their children needed. Parents ... likely than others to say their insurance coverage did not ...
... Despite the fact that an estimated 25 million ... general anesthesia, scientists have only been able to hypothesize ... They previously thought that the processes of "going under" ... the same way. Now, researchers at the University of ...
... Va.SNM supports the U.S. Senate in its introduction of ... and Radiation Therapy Act of 2010 (CARE Act), S. ... by Sen. Mike Enzi [R-WY], aims to ensure that ... are set at the state level. The bill,s co-sponsors ...
... Melissa Lee Phillips HealthDay Reporter , WEDNESDAY, Aug. ... to an inheritable eye disease that affects 5 percent of ... for transplants of the cornea. The genetic disorder, ... the cornea -- the thin, clear membrane that covers the ...
... Reporter , WEDNESDAY, Aug. 25 (HealthDay News) -- U.S. ... U.S. judge to halt any expansion of stem cell ... basically blindsided the scientific community, effectively takes embryonic stem ... when then-President George W. Bush ordered that federal monies ...
Cached Medicine News:Health News:Scientists find link in humans between nerve cell production, memory 2Health News:Scientists find link in humans between nerve cell production, memory 3Health News:Even Before Recession, 14 Million Kids 'Underinsured': Study 2Health News:Even Before Recession, 14 Million Kids 'Underinsured': Study 3Health News:Penn study sheds light on how the brain shifts between sleep/awake states under anesthesia 2Health News:SNM applauds US Senate's introduction of CARE Act 2Health News:Study Links Gene to Serious Eye Disease 2Health News:Obama to Appeal Stem Cell Ruling 2Health News:Obama to Appeal Stem Cell Ruling 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: